Patient Pathfinder: Clinical Trials
Clinical Trials for Ovarian Cancer
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 444 active Ovarian Cancer trials
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
Study Type: Interventional Phase 3
ZEN003694 Combined With Niraparib in Patients With Metastatic or Recurrent Solid Tumors
Study Type: Interventional Phase 1
Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial
Study Type: Interventional Phase 2
Value-based Integrated Recommendation Software Guiding Ovarian Cancer Treatment (VIRGO2)
Study Type: Interventional
A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors
Study Type: Interventional Phase 1
Upfront Maintenance Olaparib in Advanced Ovarian Cancer BRCAwt Patients With Known Homologous Recombination Deficiency
Study Type: Interventional Phase 2
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
Study Type: Interventional Phase 1
A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2
Study Type: Interventional Phase 2
There are 444 active Ovarian Cancer trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now